AFT PHARMACEUTICALS LIMITED AFT Pharmaceuticals (NZX.AFT, ASX.AFP) independent director Jon Lamb has announced his intention to retire as a director of the company, following the recruitment and appointment of a replacement independent director to the Board.
Chair David Flacks said: "On behalf of the Board I would like to extend my thanks to Jon for his outstanding service during his 11-year tenure. His deep industry knowledge and experience has enabled him to make a significant contribution to the growth and success of AFT, and it has been a privilege to work alongside him."
The Board will now commence a recruitment process for a replacement director, and further details will be announced in due course.
Released for and on behalf of AFT Pharmaceuticals limited by Malcolm Tubby, Chief Financial Officer.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
AFT Pharmaceuticals Limited published this content on 10 August 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 10 August 2023 08:07:04 UTC.
